Biologics Supplier for Sarasota Medspas and Aesthetic Practices

Physician supervision and vendor review for medspas

Medspas that offer services involving human tissue or cell products are generally required to operate under the supervision of a licensed physician, and vendor review for those products typically runs through that physician or a designated medical director rather than general practice staff. The review usually covers the same set of documents a dermatology or plastic surgery practice would request: a certificate of analysis for the lot, a donor eligibility summary, and a description of processing and testing. Because medspas vary widely in staffing, it helps to identify the supervising physician by name during account setup so documentation requests have a single point of contact.

Account verification requirements

Precision Biologics requires a National Provider Identifier to open an account and limits orders to licensed professionals, which for a medspa generally means the account is registered to the supervising physician rather than the business entity itself. This keeps the ordering relationship and lot documentation tied to a credentialed individual.

Cold-chain intake for aesthetic practices

Cryopreserved Wharton's jelly products arrive overnight on dry ice in validated shipping containers and need immediate transfer to -80 C storage; lyophilized exosome products ship shelf-stable and store at room temperature according to the insert included with that lot. A medspa or dermatology office without existing cryogenic storage should confirm freezer capacity before ordering cryopreserved formats, and should plan deliveries around days when a licensed staff member is present to receive and log the shipment.

• Confirm -80 C freezer capacity before ordering cryopreserved formats
• Schedule deliveries for days when licensed staff can receive and log them
• Match the lot number on arrival to the packing slip before storage

Documentation and account support

Florida practices should verify their own regulatory posture directly with the Florida Board of Medicine and independent counsel; Florida's SB 1768, effective since July 1, 2025, is limited to physician use of certain non-FDA-approved stem cell therapies in orthopedics, wound care, and pain management and does not extend to aesthetic use or override federal FDA requirements. Precision Biologics makes registration and licensure documentation, certificates of analysis, and ingredient disclosures available to verified accounts, and can arrange a documentation-focused call between a requesting physician and a peer.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.